SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-21-098917
Filing Date
2021-08-02
Accepted
2021-08-02 16:39:31
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 tm2123236-1_s3.htm S-3 294217
2 EXHIBIT 5.1 tm2123236d2_ex5-1.htm EX-5.1 10616
3 EXHIBIT 23.1 tm2123236d2_ex23-1.htm EX-23.1 1931
4 GRAPHIC tm2123236d2_ex5-1img1.jpg GRAPHIC 12849
5 GRAPHIC tm2123236d2_ex5-1img2.jpg GRAPHIC 1655
6 GRAPHIC lg_entasis-4c.jpg GRAPHIC 74188
  Complete submission text file 0001104659-21-098917.txt   430437
Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 (781) 810-0120
Entasis Therapeutics Holdings Inc. (Filer) CIK: 0001724344 (see all company filings)

IRS No.: 824592913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-258371 | Film No.: 211136570
SIC: 2834 Pharmaceutical Preparations